Product News Lilly Receives European Marketing Authorization for tirzepatide in KwikPen® Presentation for Two Indications 30 April 2024
Product News Astellas’ Veoza™ (fezolinetant) now available in Ireland for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause 30 April 2024
